151 related articles for article (PubMed ID: 25192652)
1. Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab')2.
Zhao Z; Fan C; Duan Y; Zhang L; Li M; Yang X; Li R; Yang P; Wang X
Int Immunopharmacol; 2014 Nov; 23(1):134-8. PubMed ID: 25192652
[TBL] [Abstract][Full Text] [Related]
2. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
3. Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab')2 against highly pathogenic avian influenza H5N1 in mice.
Zhao Z; Yan F; Chen Z; Luo D; Duan Y; Yang P; Li Z; Peng D; Liu X; Wang X
Int Immunopharmacol; 2011 Dec; 11(12):2000-6. PubMed ID: 21906698
[TBL] [Abstract][Full Text] [Related]
4. Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice.
Herbreteau CH; Jacquot F; Rith S; Vacher L; Nguyen L; Carbonnelle C; Lotteau V; Jolivet M; Raoul H; Buchy P; Saluzzo JF
Immunotherapy; 2014; 6(6):699-708. PubMed ID: 24673720
[TBL] [Abstract][Full Text] [Related]
5. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
6. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
7. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
[TBL] [Abstract][Full Text] [Related]
8. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
[TBL] [Abstract][Full Text] [Related]
9. A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin.
Yu F; Song H; Wu Y; Chang SY; Wang L; Li W; Hong B; Xia S; Wang C; Khurana S; Feng Y; Wang Y; Sun Z; He B; Hou D; Manischewitz J; King LR; Song Y; Min JY; Golding H; Ji X; Lu L; Jiang S; Dimitrov DS; Ying T
Cell Host Microbe; 2017 Oct; 22(4):471-483.e5. PubMed ID: 28966056
[TBL] [Abstract][Full Text] [Related]
10. Equine Immunoglobulin and Equine Neutralizing F(ab')₂ Protect Mice from West Nile Virus Infection.
Cui J; Zhao Y; Wang H; Qiu B; Cao Z; Li Q; Zhang Y; Yan F; Jin H; Wang T; Sun W; Feng N; Gao Y; Sun J; Wang Y; Perlman S; Zhao J; Yang S; Xia X
Viruses; 2016 Dec; 8(12):. PubMed ID: 27999340
[TBL] [Abstract][Full Text] [Related]
11. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
[TBL] [Abstract][Full Text] [Related]
12. Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.
Wang X; Ni B; Du X; Zhao G; Gao W; Shi X; Zhang S; Zhang L; Wang D; Luo D; Xing L; Jiang H; Li W; Jiang M; Mao L; He Y; Xiao Y; Wu Y
Antivir Ther; 2005; 10(5):681-90. PubMed ID: 16152762
[TBL] [Abstract][Full Text] [Related]
13. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus Is Related to Its Internal Genes.
Lee AC; Zhu H; Zhang AJ; Li C; Wang P; Li C; Chen H; Hung IF; To KK; Yuen KY
Clin Vaccine Immunol; 2015 Dec; 22(12):1235-43. PubMed ID: 26446420
[TBL] [Abstract][Full Text] [Related]
15. Single immunization with MF59-adjuvanted inactivated whole-virion H7N9 influenza vaccine provides early protection against H7N9 virus challenge in mice.
Chang H; Duan J; Zhou P; Su L; Zheng D; Zhang F; Fang F; Li X; Chen Z
Microbes Infect; 2017 Dec; 19(12):616-625. PubMed ID: 28899814
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
[TBL] [Abstract][Full Text] [Related]
17. Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates.
Pan W; Han L; Dong Z; Niu X; Li Z; Bao L; Li C; Luo Q; Yang Z; Li X; Huang J; Feng L; Qin C; Zhong N; Chen L
Antiviral Res; 2014 Jul; 107():1-5. PubMed ID: 24746458
[TBL] [Abstract][Full Text] [Related]
18. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
Henry Dunand CJ; Leon PE; Kaur K; Tan GS; Zheng NY; Andrews S; Huang M; Qu X; Huang Y; Salgado-Ferrer M; Ho IY; Taylor W; Hai R; Wrammert J; Ahmed R; García-Sastre A; Palese P; Krammer F; Wilson PC
J Clin Invest; 2015 Mar; 125(3):1255-68. PubMed ID: 25689254
[TBL] [Abstract][Full Text] [Related]
19. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.
Wilson JR; Guo Z; Reber A; Kamal RP; Music N; Gansebom S; Bai Y; Levine M; Carney P; Tzeng WP; Stevens J; York IA
Antiviral Res; 2016 Nov; 135():48-55. PubMed ID: 27713074
[TBL] [Abstract][Full Text] [Related]
20. [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].
Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
J Cardiol; 2005 Jun; 45(6):247-55. PubMed ID: 15991608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
